COVID-19

The drug will be marketed under Vivimed’s brand name ‘Favulous’ across India

Baricitinib was issued a restricted emergency use approval by CDSCO to treat COVID-19  

There is also a high risk to subjects in a clinical trial who have serious chronic or acute condition that affects their immune…

The Government should try to incentivise directly the foreign companies which own the patents for the other COVID-19 vaccines also…

The government has started importing the vital drug Remdesivir from other countries to ease its shortage in the country

The schemes facilitate funding to MSMEs for production and services related to supply of oxygen cylinders, oxygen concentrators,…

According to the letter, there are several steps that vaccine companies could take to expand access to the vaccines globally,…

Nevertheless, respondents across all geographies believed that investments in blockchain should pick up in the next two years

The proposed oral treatment is expected to be for five days

Further follow-up on the long-term effects of the disease needs to be conducted, along with treatments to prevent these outcomes